Studies in large cohorts of primary AML patient specimens excluded the occurrence of RKIP mutations, copy number deletions, as well as the hypermethylation of the RKIP promoter region [54,56,67]. This evidence concerns the gene PEBP1 and acute myeloid leukemia.